Our Treatments
Spravato & Ketamine Treatment Options
We offer two treatment pathways — FDA-approved Spravato and IV ketamine infusions — both administered in a safe, monitored environment by experienced clinical staff.
Spravato Treatment for Treatment-Resistant Depression
Spravato is an FDA-approved nasal spray indicated for Treatment-Resistant Depression and Major Depressive Disorder with or without suicidality. Administered onsite under supervision, each session is 2 hours.
Requires a psychiatry referral — we help patients connect with a psychiatrist if needed.
Initial Phase
Twice weekly for 4 weeks → once weekly for 4 weeks → once every two weeks for 4 weeks
Maintenance Phase
Treatments as needed
Insurance
Covered by nearly all major carriers. BCBS MS and Cigna not currently accepted.
IV Ketamine Infusion Treatment
Sub-anesthetic ketamine delivered intravenously has shown higher efficacy rates than traditional treatments alone. Every infusion is personalized — we titrate doses and customize protocols for each patient.
All ketamine infusion patients are continuously monitored by a critical-care RN throughout every session.
Ketamine for Mood Disorders
Treatment-Resistant Depression, PTSD, Post-Partum Depression, Suicidality, Generalized Anxiety Disorder
Initial Phase
$2,400 totalSix one-hour infusions over three weeks
Maintenance Phase
$400/infusionSingle two-hour infusion as needed
Ketamine for Chronic Pain
Fibromyalgia, Neuropathy, Phantom Limb Pain, Complex Regional Pain Syndrome (CRPS)
Initial Phase
$1,200 totalThree four-hour infusions over three days
Maintenance Phase
$400/infusionSingle four-hour infusion as needed
All ketamine infusions are $400 per visit, cash pay only. Doses are titrated and protocols are personalized for each patient. Continuous critical-care RN monitoring throughout every session.
Ready to explore Spravato or ketamine treatment?
We're happy to discuss whether Spravato or ketamine may be right for you or your patient.